This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Yumanity Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.42m |
| Equity | US$5.48m |
| Total liabilities | US$4.10m |
| Total assets | US$9.58m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8IY's short term assets ($9.1M) exceed its short term liabilities ($4.1M).
Long Term Liabilities: 8IY has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 8IY is debt free.
Reducing Debt: 8IY had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8IY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 8IY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15% each year